98 related articles for article (PubMed ID: 7310528)
21. [Serum ferritin assay in the evaluation of the loco-regional spread of gastric cancer].
Gioffré Florio MA; Venuti A; Caputo G; La Rosa M; Giorgianni G; Micali B
Bull Cancer; 1983; 70(3):174-6. PubMed ID: 6882933
[No Abstract] [Full Text] [Related]
22. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay.
Hu XC; Chow LW
Anticancer Res; 2001; 21(1A):421-4. PubMed ID: 11299772
[TBL] [Abstract][Full Text] [Related]
23. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
[TBL] [Abstract][Full Text] [Related]
24. [Ferritin and breast cancer].
Claustres M; Belaroussi N; Guilleux F; Magnan de Bornier B
Pathol Biol (Paris); 1984 Apr; 32(4):265-8. PubMed ID: 6718068
[TBL] [Abstract][Full Text] [Related]
25. Serum hCG in bronchogenic carcinoma.
Behera D; Dash S; Malik SK; Dash RJ
Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265
[No Abstract] [Full Text] [Related]
26. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
[TBL] [Abstract][Full Text] [Related]
27. Biochemical markers in breast carcinoma.
Duffy MJ; Hynes N; Groarke Y; Oliver J; O'Broin A; Duffy G
Ir Med J; 1978 Sep; 71(12):408-13. PubMed ID: 700980
[No Abstract] [Full Text] [Related]
28. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
29. Human chorionic gonadotropin in cancer.
Stenman UH; Alfthan H; Hotakainen K
Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
[TBL] [Abstract][Full Text] [Related]
30. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
[TBL] [Abstract][Full Text] [Related]
31. Surgery-related shedding of breast cancer cells as determined by RT-PCR assay.
Hu XC; Loo WT; Chow LW
J Surg Oncol; 2003 Apr; 82(4):228-32; discussion 233. PubMed ID: 12672005
[TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotropin (hCG) and prevention of breast cancer.
Janssens JP; Russo J; Russo I; Michiels L; Donders G; Verjans M; Riphagen I; Van den Bossche T; Deleu M; Sieprath P
Mol Cell Endocrinol; 2007 Apr; 269(1-2):93-8. PubMed ID: 17386970
[TBL] [Abstract][Full Text] [Related]
33. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
34. Serum parameters of iron metabolism in patients with breast cancer.
Ulbrich EJ; Lebrecht A; Schneider I; Ludwig E; Koelbl H; Hefler LA
Anticancer Res; 2003; 23(6D):5107-9. PubMed ID: 14981974
[TBL] [Abstract][Full Text] [Related]
35. [Detection of serum CEA mRNA and CEA proteins in patients with breast cancer and its clinical significance].
Jin T; Chen DF; Gu LH
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):214-5. PubMed ID: 17649640
[No Abstract] [Full Text] [Related]
36. The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients.
Vrdoljak DV; Knezevic F; Ramljak V
Saudi Med J; 2006 Apr; 27(4):460-2. PubMed ID: 16598320
[TBL] [Abstract][Full Text] [Related]
37. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
38. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
[TBL] [Abstract][Full Text] [Related]
39. Biologic markers and breast cancer.
Waalkes TP; Tormey DC
Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
[No Abstract] [Full Text] [Related]
40. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
